GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Rating of "Moderate Buy" by Brokerages

Key Points

• GE HealthCare Technologies Inc. has received an average rating of "Moderate Buy" from eleven brokerages, with eight analysts recommending a buy rating and one a strong buy.
• The company's quarterly earnings exceeded expectations, reporting $1.06 EPS compared to a consensus estimate of $0.91, alongside a revenue of $5 billion, up 3.5% year-over-year.
• GE HealthCare Technologies announced a quarterly dividend of $0.035 per share, reflecting an annualized yield of 0.2% and a payout ratio of 2.87%.

GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) has earned an average rating of "Moderate Buy" from the eleven brokerages that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $88.40.

GEHC has been the subject of several recent research reports. Zacks Research raised shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 28th. Citigroup increased their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. Wall Street Zen raised GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Morgan Stanley lowered their target price on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating on the stock in a research note on Thursday, July 31st. Finally, BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th.

GE HealthCare Technologies Trading Up 0.7%

GE HealthCare Technologies stock opened at $78.71 on Wednesday. The stock has a 50-day moving average price of $74.42 and a 200 day moving average price of $73.83. The company has a market capitalization of $35.94 billion, a price-to-earnings ratio of 16.13, a price-to-earnings-growth ratio of 2.99 and a beta of 1.13. GE HealthCare Technologies has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the prior year, the company earned $1.00 EPS. GE HealthCare Technologies's quarterly revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies's payout ratio is 2.87%.

Institutional Trading of GE HealthCare Technologies

Hedge funds have recently added to or reduced their stakes in the company. Cetera Investment Advisers raised its position in shares of GE HealthCare Technologies by 2.9% in the fourth quarter. Cetera Investment Advisers now owns 79,544 shares of the company's stock worth $6,219,000 after acquiring an additional 2,244 shares during the period. D. E. Shaw & Co. Inc. increased its stake in shares of GE HealthCare Technologies by 44.8% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 25,810 shares of the company's stock valued at $2,018,000 after purchasing an additional 7,980 shares in the last quarter. Ensign Peak Advisors Inc increased its stake in shares of GE HealthCare Technologies by 15.8% in the 4th quarter. Ensign Peak Advisors Inc now owns 78,790 shares of the company's stock valued at $6,160,000 after purchasing an additional 10,770 shares in the last quarter. Janus Henderson Group PLC raised its holdings in GE HealthCare Technologies by 21.4% in the 4th quarter. Janus Henderson Group PLC now owns 62,620 shares of the company's stock worth $4,895,000 after purchasing an additional 11,041 shares during the period. Finally, Investment Management Corp of Ontario boosted its position in GE HealthCare Technologies by 6.6% during the fourth quarter. Investment Management Corp of Ontario now owns 15,251 shares of the company's stock worth $1,192,000 after purchasing an additional 941 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.